A search of PubMed shows that in 1960, the year I was born, there were 110 publications on obesity. In 1991, the year I graduated from Mayo Medical School, the number had risen to 406 publications. By contrast, in 2015 there were 5470 publications on obesity. The last quarter of a century has led to the recognition of a world-wide epidemic of overweight and obesity, with a rise in all their complications. [1] [2] [3] And with this recognition came the need to understand the underlying physiology and pathophysiology, and the eventual development of therapeutic interventions. [4] [5] [6] It is now clear that the accretion of adipose tissue (adiposity) leads to physical complications (i.e. sleep apnea, gastroesophageal reflux disease, degenerative osteoarthritis, and dermopathy). It is also universally recognized that adipose tissue is not just an energy storage organ.
Rather, adipose tissue is an endocrine organ which actively makes and responds to hormones. As such, adipose tissue is a major contributor to energy homeostasis.
An emerging concept is that derangements of adipose tissue function contribute to the genesis of metabolic diseases (i.e. diabetes, hypertension, dyslipidemia, cardiovascular disease). My colleague, Harold Bays, introduced the concept of adiposopathy (sick fat) into the medical literature. 7, 8 Adiposopathy defines the anatomic and functional changes that lead to adipose tissue dysfunction, and thus contribute to metabolic diseases. to pharmacotherapy, to the use of devices, and surgery for weight loss. [13] [14] [15] [16] Under the leadership of Bob Kushner, the American Board of Obesity For now, it is exciting to me that a new generation of physicians is learning about overweight, obesity, and adiposopathy as diseases that can and should be diagnosed and treated. Obesity medicine has come of age, and bariatric endocrinology is here and growing! ■
